跳转至内容
Merck
CN

BP578

地塞米松

British Pharmacopoeia (BP) Assay Standard

别名:

(11β,16α)-9-氟-11,17,21-三羟基-16-甲基孕甾-1,4-二烯-3,20-二酮, 9α-氟-16α-甲基-11β,17α,21-三羟基-1,4-妊娠双烯-3,20-二酮, 9α-氟-16α-甲基泼尼松龙, 泼尼松龙F

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C22H29FO5
CAS号:
分子量:
392.46
Beilstein:
2066651
EC 号:
MDL编号:
UNSPSC代码:
41116107
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

dexamethasone

形式

solid

保质期

limited shelf life, expiry date on the label

制造商/商品名称

BP

mp

262-264 °C (lit.)

应用

pharmaceutical
pharmaceutical small molecule

格式

neat

储存温度

2-8°C

SMILES字符串

C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

InChI

1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1

InChI key

UREBDLICKHMUKA-CXSFZGCWSA-N

基因信息

human ... NR3C1(2908)

正在寻找类似产品? 访问 产品对比指南

一般描述

该产品在交付时提供并符合现行药典规定。随附的本产品的所有支持信息,包括SDS和任何产品信息彩页,均遵照现行药典许可而编制和发布。
更多信息和支持,请见现行药典网站。

应用

Dexamethasone BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Tobramycin and Dexamethasone Eye Drops, Suspension
  • Dexamethasone Sodium Phosphate Oral Solution
  • Hydrocortisone Sodium Succinate Injection
  • Prednisolone Tablets
  • Dexamethasone Eye Drops, Suspension
  • Dexamethasone Sodium Phosphate Eye Drops, Solution
  • Dexamethasone and Neomycin Ear Spray
  • Betamethasone Tablets
  • Dexamethasone Tablets
  • 生化/生理作用

    糖皮质激素抗炎剂。 调节T细胞生存、生长和分化。抑制一氧化氮合酶活性的诱导。

    其他说明

    可能适用相应的销售限制。

    相关产品

    产品编号
    说明
    价格

    象形图

    Health hazard

    警示用语:

    Danger

    危险声明

    危险分类

    Repr. 1B

    WGK

    WGK 3

    闪点(°F)

    Not applicable

    闪点(°C)

    Not applicable

    法规信息

    监管及禁止进口产品

    Choose from one of the most recent versions:

    分析证书(COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Alexandre Denoyer et al.
    Ophthalmology, 122(4), 669-676 (2014-12-03)
    To compare small incision lenticule extraction (SMILE) versus LASIK for post-refractive dry eye disease. Prospective, comparative, nonrandomized clinical study. Thirty patients scheduled for bilateral myopic SMILE and 30 age-, sex-, and refraction-matched patients scheduled for bilateral myopic LASIK were enrolled
    Michael J White et al.
    Cell, 159(7), 1549-1562 (2014-12-20)
    Activated caspases are a hallmark of apoptosis induced by the intrinsic pathway, but they are dispensable for cell death and the apoptotic clearance of cells in vivo. This has led to the suggestion that caspases are activated not just to kill
    D Rhebergen et al.
    Psychoneuroendocrinology, 51, 341-350 (2014-12-03)
    Altered functioning of the hypothalamic-pituitary-adrenal axis (HPA-axis) has been associated with depression, but findings have been inconsistent. Among older depressed persons, both hyperactivity and hypo-activity of the HPA-axis were demonstrated. However, most studies were population-based studies, with single cortisol measurements
    Yijin Wang et al.
    Gastroenterology, 146(7), 1775-1783 (2014-03-04)
    Many recipients of organ transplants develop chronic hepatitis, due to infection with the hepatitis E virus (HEV). Although chronic HEV infection is generally associated with immunosuppressive therapies, little is known about how different immunosuppressants affect HEV infection. A subgenomic HEV
    A Keith Stewart et al.
    The New England journal of medicine, 372(2), 142-152 (2014-12-09)
    Lenalidomide plus dexamethasone is a reference treatment for relapsed multiple myeloma. The combination of the proteasome inhibitor carfilzomib with lenalidomide and dexamethasone has shown efficacy in a phase 1 and 2 study in relapsed multiple myeloma. We randomly assigned 792

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门